PuSH - Publication Server of Helmholtz Zentrum München: Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial.

Navigation

Research

Browse by ...

... Journal

Support & Contact

Lichtenegger, F.S. ; Schnorfeil, F.M. ; Koehnke, T.* ; Altmann, T. ; Buecklein, V.* ; Moosmann, A. ; Brueggemann, M.* ; Wagner, B.* ; Hiddemann, W. ; Bigalke, I. ; Kvalheim, G.* ; Subklewe, M.

Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial.

Cancer Immunol. Res. 4:B146 (2016)

Open Access Green as soon as Postprint is submitted to ZB.

Additional Metrics?

Edit extra informations Login

Publication type Article: Journal article

Document type Meeting abstract

Corresponding Author

ISSN (print) / ISBN 2326-6066

e-ISSN 2326-6074

Journal Cancer Immunology Research

Quellenangaben Volume: 4, Issue: 1, Article Number: B146

Publisher AACR

Publishing Place Philadelphia, Pa.

Non-patent literature Publications

Reviewing status Peer reviewed